2025 Annual Report


Cure Alzheimer’s Fund is a nonprofit organization dedicated to funding research with the highest probability of preventing, slowing, or reversing Alzheimer’s disease.

The year 2025 tested the resilience of our Cure Alzheimer’s Fund community. Unprecedented disruptions in U.S. government funding and priorities challenged the biomedical research ecosystem that has yielded vital knowledge and progress in Alzheimer’s and across human health. Yet our researchers and donors persevered, focused despite all distractions on our shared goal to end Alzheimer’s disease.

Together, we ensured that momentum was not lost and that progress toward our mission continued without pause. In 2025, Cure Alzheimer’s Fund achieved a record high in research investment, deploying $38.3 million—a 27% increase above 2024. Our program supported 167 grants and 187 investigators advancing work across the full spectrum of Alzheimer’s research.

“The gratitude within the research community is fueling renewed momentum to advance science and bring more therapies to patients.”
—Meg Smith, CureAlz CEO

View the 2025 Annual Report Scrolling Story Here

ON THE COVER: Astrocyte Galaxy (A 3D network of astrocytes in the mouse brain). Learn how the image was created here.

IMAGE CREDIT: Melissa Cooper, Ph.D., a postdoctoral researcher in the lab of Shane A. Liddelow, Ph.D., at New York University Grossman School of Medicine.

View the the 2025 Annual Report in
magazine format or as printable PDF.